Nuverah Mohsin, MD, BS

Fox Chase Cancer Center
Philadelphia, PA

Disclosures:

• Employment: none
• Compensation: :Role Topic Description-End Date:
• Ownership: none
• Leadership: none

Presentation(s):

• 1022 - ACRIN 6685 PET-CT Threshold to Reinterpret Pre-Treatment Head and Neck Cancer (HNC) Imaging? Stage Migration and Treatment Outcomes

  Monday, September 30, 2024
  5:25 PM – 5:30 PM ET